The June, 2004 edition of Journal of Perinatology presented a study titled “Transient neonatal jitteriness due to maternal use of sertraline (Zoloft).” by R.P. Santos et al., providing important insight into the link between Zoloft expousre during pregnancy and adverse birth outcomes. Here is the abstract of that article:
“We describe the occurrence of marked jitteriness and an enhanced startle response in a term infant after being exposed to sertraline in utero. An umbilical cord blood sample taken at the time of birth showed a sertraline concentration (<10 ng/mL) below the reference range. On the third day during the peak of the symptoms, sertraline plasma concentration was <10 ng/mL, while his serotonin level (6 ng/mL) was below the reference range. The neurologic symptoms resolved by the fifth day. To date, there are no reports of transient neonatal jitteriness with maternal use of sertraline documented with low cord and neonatal plasma samples consistent with withdrawal syndrome.”
Because so many women have used Zoloft during pregnancy unaware of the risks for Zoloft birth defects, a great number of Zoloft® birth defects lawsuits have been filed. If you or a loved one used Zoloft and gave birth to a child with a congenital malformation or who had perinatal complications, you may be entitled to significant financial compensation. For a free, no-obligation case consultation, contact our team of Zoloft® birth defects lawyers at the information provided below. We have the experience, resources, and skills required to win the justice you deserve. Call today and see how we can help.
(855) 452 – 5529